ANTI-DIABETIC EFFECT OF A NOVEL NANO POLYMER OF THYMOL IN STREPTOZOTOCIN-INDUCED DIABETIC WISTAR RATS
Objective: The aim of this study was to evaluate the effect of thymol and thymol nano polymer on the blood biochemical parameters and anti-diabetic activity in Streptozotocin (STZ)-induced diabetic rats.
Methods: The synthesized nano polymer (NP) was characterized by using different spectroscopy methods, such as IR, HNMR and CNMR. Loading and releasing of thymol were investigated by HPLC. Eleven groups of the Streptozotocin-induced diabetic and normal rats (overall 110 males) were tested through various biochemical factors such as: serum glucose, insulin, liver function-related enzymes including ALT, AST, ALP and bilirubin by ELISA kit methods.
Results: It has shown that thymol nano polymer is desirable for transferring drug. The amount of thymol loaded on NP estimated at 43±2.5 %. Then, 65% of the loaded drug was released. LD50 for thymol and thymol nano polymer were 435 and 583 mg/kg, respectively. thymol nano polymer at doses of 30, 60 and 90 mg/kg, in a dose-dependent manner, reduced blood glucose, increased insulin levels, and controlled liver enzymes ALT, AST, ALP and bilirubin in the STZ-induced diabetic rats.
Conclusion: The use of thymol nano polymer appears to be a new aspect concerning to protect diabetes-induced damage in the animal model.
2. Vetere A. Targeting the pancreatic beta-cell to treat diabetes. Nat Rev Drug Discovery 2014;13:278-89.
3. Jayaraman R. Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats. Biomed Pharmacother 2018;97:98-106.
4. Guven A. Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem 2006;108:85-93.
5. Kaysen GA. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 2002;61:2240-9.
6. Machry RV. A multifactorial intervention for diabetes control among older users of insulin. Rev Saude Publica; 2018. p. 52.
7. Khavandi K. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis 2013;4:242-61.
8. Cai Y. Hypoglycemic activity of two anthraquinone derivatives from Juncus setchuensis Buchen. Int J Clin Exp Med 2016;9:19664-72.
9. Jose D, NA Aleykutty, J Harindran. Effect of the combination of two plant extracts on diabetes mellitus. Int J Pharm Pharm Sci 2018;10:49-52.
10. HNS, YHN. Efficacy of an active compound of the herb, ashwagandha in the prevention of stress-induced hyperglycemia. Int J Pharm Pharm Sci 2018;10:44-9.
11. Nabavi SM. Plants belonging to the genus thymus as antibacterial agents: from farm to pharmacy. Food Chem 2015;173:339-47.
12. Kim DO, CY Lee. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr 2004;44:253-73.
13. Fachini Queiroz FC. Effects of thymol and carvacrol, constituents of thymus vulgaris l. essential oil, on the inflammatory response. Evid Based Complement Alternat Med 2012. p. 657026. http://dx.doi.org/10.1155/2012/657026
14. Lou SN, YS Hsu, CT Ho. Flavonoid compositions and antioxidant activity of calamondin extracts prepared using different solvents. J Food Drug Anal 2014;22:290-5.
15. Do QD. Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of limnophila aromatica. J Food Drug Anal 2014;22:296-302.
16. Saravanan S, L Pari. Role of thymol on hyperglycemia and hyperlipidemia in high-fat diet-induced type 2 diabetic C57BL/6J mice. Eur J Pharmacol 2015;761:279-87.
17. Robledo N. Thymol nanoemulsions incorporated in quinoa protein/chitosan edible films; antifungal effect in cherry tomatoes. Food Chem 2018;246:211-9.
18. Jafari A. Hepatoprotective effect of thymol against subchronic toxicity of titanium dioxide nanoparticles: biochemical and histological evidences. Environ Toxicol Pharmacol 2018;58:29-36.
19. Park W, K Na. Advances in the synthesis and application of nanoparticles for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015;7:494-508.
20. Adeli M. Hyperbranched poly (citric acid) and its application as anticancer drug delivery system. J Appl Polymer Sci 2013;129:3665-71.
21. Dong Q, L Gu. Synthesis of AN-g-casein copolymer in the concentrated aqueous solution of sodium thiocyanate and AN-g-casein fiber's structure and property. Eur Polymer J 2002;38:511-9.
22. Neri D. Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressors by biosynthetically directed fractional carbon-13 labeling. Biochemistry 1989;28:7510-6.
23. Adams ML, A Lavasanifar, GS Kwon. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343-55.
24. Lv Q. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm 2009;372:191-8.
25. Majumdar D. Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev Res (Phila) 2014;7:65-73.
26. Qiao M. Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int J Pharm 2005;294:103-12.
27. Botham PA. Acute systemic toxicity. ILAR J 2002;43(Suppl 1) :S27-S30.
28. Gad Elkareem, MAM. Potential antidiabetic effect of ethanolic and aqueous-ethanolic extracts of ricinus communis leaves on streptozotocin-induced diabetes in rats. Peer J 2019;7:e6441-e6441.
29. Alvarez Echazu MI. Development and evaluation of thymol-chitosan hydrogels with antimicrobial-antioxidant activity for local oral delivery. Mater Sci Eng C Mater Biol Appl 2017;81:588-96.
30. Kolhe P. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm 2003;259:143-60.
31. Zhang H. Hyperbranched poly(amine-ester) based hydrogels for controlled multi-drug release in combination chemotherapy. Biomaterials 2010;31:5445-54.
32. Dulak J. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008; 117:231-41.
33. Meissner G. Ryanodine activation and inhibition of the Ca2+release channel of sarcoplasmic reticulum. J Biol Chem 1986;261:6300-6.
34. Verma A. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 2008;7:588-95.
35. Medina E. Chitosan thymol nanoparticles improve the antimicrobial effect and the water vapour barrier of chitosan-quinoa protein films. J Food Eng 2019;240:191-8.
36. Wattanasatcha A, S Rengpipat, S Wanichwecharungruang. Thymol nanospheres as an effective anti-bacterial agent. Int J Pharm 2012;434:360-5.
37. Patel T. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Delivery Rev 2012; 64:701-5.
38. Pivetta TP. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Colloids Surf B Biointerfaces 2018;164:281-90.
39. Mattos BD. Controlled biocide release from hierarchically-structured biogenic silica: surface chemistry to tune release rate and responsiveness. Sci Reports 2018;8:5555.
40. Ramesh C, A Prameela Rani. In vivo and in vitro evaluation of tephrosia calophylla for anti-diabetic properties. Int J Pharm Pharm Sci 2018;10:138-44.
41. Saravanan S, L Pari. Protective effect of thymol on high-fat diet-induced diabetic nephropathy in C57BL/6J mice. Chem Biol Interact 2016;245:1-11.
42. Haque MR. Monoterpene phenolic compound thymol prevents high-fat diet-induced obesity in the murine model. Toxicol Mech Methods 2014;24:116-23.
43. Cheng D, B Liang, Y Li. Antihyperglycemic effect of ginkgo biloba extracts in streptozotocin-induced diabetes in rats. BioMed Res Int 2013. p. 7. http://dx.doi.org/10.1155/2013/162724
44. Zafar M, S Naeem-ul-Hassan Naqvi. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 2010;28:135-42.
45. Aghamohammadi A, M Azadbakht, SJ Hosseinimehr. Quantification of thymol content in different extracts of zataria multiflora by HPLC method. Pharm Biomed Res 2016;2:8-13.
46. mahmoodi M. The protective effect of zataria multiflora boiss hydroalcoholic extract on TNF-? production, oxidative stress, and insulin level in streptozotocin-induced diabetic rats. Avicenna J Phytomed 2019;9:72-83.
47. Çam M. Antidiabetic effects of salvia triloba and thymus praecox subsp. Skorpilii var. skorpilii in a rat model of streptozotocin/nicotinamide-induced diabetes. Marmara Pharm J 2017;21:818-27.
48. Oskouei BG. In vivo evaluation of anti-hyperglycemic, anti-hyperlipidemic and antioxidant status of liver and kidney of thymol in STZ-induced diabetic rats. Drug Res (Stuttg) 2019;69:46-52.
49. Abedi Gaballu F. Effects of a triplex mixture of peganum harmala, Rhus coriaria, and Urtica dioica aqueous extracts on metabolic and histological parameters in diabetic rats. Pharm Biol 2015;53:1104-9.
50. Reddy D. Effect of holostemma annularis on the progression of diabetes-induced by a high fructose diet in rats and in diabetic C57BL/6J ob/ob mice. Diabetes Metab Syndr Obes: Targets Ther 2010;3:87-94.
51. Kavoosi G, S Balotf. Zataria multiflora essential oil reduces diabetic damages in streptozotocin-induced diabetic rats. Afr J Biotechnol 2011;10:17632-9.
52. Ajiboye BO. Ameliorative activity of ethanolic extract of artocarpus heterophyllus stem bark on alloxan-induced diabetic rats. Adv Pharm Bull 2018;8:141-7.
53. Basri D. Protective effect of aqueous extracts from canarium odontophyllum miq. leaf on liver in streptozotocin-induced diabetic rats. Life Sci Med Biomed 2018;2:1-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.